ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$27.29
-0.16 (-0.58%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+11.25%
YTD
+3.80%
Open$27.37
Previous Close$27.45
Day High$27.48
Day Low$26.73
52W High$30.96
52W Low$19.69
Volume—
Avg Volume1.39M
Market Cap4.65B
P/E Ratio12.21
EPS$2.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.91
Above
SMA 200
$23.44
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-34.4% upside
Current
$27.29
$27.29
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.07B | 943.00M | 1.03B |
| Net Income | 391.70M | 309.70M | 167.73M |
| Profit Margin | 36.5% | 34.7% | 16.3% |
| EBITDA | 105.88M | 88.36M | 233.13M |
| Free Cash Flow | — | — | 189.95M |
| Rev Growth | +13.8% | +13.8% | +10.0% |
| Debt/Equity | — | — | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |